Pepsi accused of illegal pricing deals with 'a large, big box retailer' in U.S. lawsuit The Federal Trade Commission is suing Pepsi, alleging it has rigged competition by offering unfair pricing deals to a big retailer at the expense of smaller rivals, resulting in higher costs for shoppers. Alina Selyukh
President-elect Donald Trump moves inauguration indoors, citing frigid temperatures President-elect Donald Trump announced Friday that he will move the inauguration ceremony indoors as Washington, DC prepares for record low temperatures. The ceremony will now take place inside the Capitol rotunda. Lexie Schapitl
Trump's inauguration falls on MLK Day. That overlap is pretty rare Trump is only the third president to be sworn in on Martin Luther King Jr. Day. Due to the particulars of the calendar and the Constitution, the two events won't overlap again until 2053. Rachel Treisman
Biden's Medicaid director shares lessons learned and concerns for the program's future Dan Tsai discusses how he ran Medicaid under Biden, and his fears for how Republicans might try to change the program. Dan Gorenstein
Supreme Court upholds TikTok ban, threatening app's existence in the U.S. The decision resolves a long-running legal dispute between the Department of Justice and TikTok. But experts say President-elect Donald Trump will now have considerable sway over the platform's future in the U.S. Bobby Allyn
Biden says the Equal Rights Amendment is law. What happens next is unclear To come into effect, the constitutional amendment would need to be formally published or certified by the national archivist, who has declined to do so in the past. What happens now is unclear. Danielle Kurtzleben
Food pantries are bracing for more demand if the Trump administration cuts food aid The first Trump administration tried to scale back who gets food benefits, and allies aim to try again. Food pantries say they're already busier than ever. Jennifer Ludden
Medicare targets 15 more drugs for price negotiations -- including Ozempic On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare. Sydney Lupkin
